Prof. Xiaowu Xu 徐晓武
Chief Physician, Professor
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Minimally invasive robotic and laparoscopic surgery for pancreatic, hepatobiliary, splenic, gastrointestinal stromal, and neuroendocrine tumors. Focuses on function-preserving procedures and comprehensive surgical management with adjuvant chemotherapy.
Dr. Xu is Deputy Director of Pancreatic Surgery and Director of the Pancreatic Minimally Invasive Surgery Center at Fudan University Shanghai Cancer Center, having joined in 2018. Trained under Professor Mou Yiping, Dr. Xu pioneered laparoscopic pancreatic and gastrointestinal surgeries in China. Previously served at Sir Run Run Shaw Hospital and Zhejiang Provincial People’s Hospital. Holds three National Natural Science Foundation grants, published over 20 SCI papers, and received the Zhejiang Provincial Science and Technology Progress Award (Second Class).
Professional roles
- Standing Committee Member, Pancreatic Cancer Professional Committee, China Anti-Cancer Association
- Member, Minimally Invasive Diagnosis and Treatment Group, Pancreatic Cancer Professional Committee, China Anti-Cancer Association
- Member, Neuroendocrine Tumor Professional Committee, China Anti-Cancer Association
- Youth Committee Member, General Surgery Branch, Shanghai Medical Association
Name order: in Chinese the family name comes first (Xu Xiaowu). Papers usually list the name as Xiaowu Xu or Xu X.
Selected publications
105 papers on PubMed matched by name and affiliation; 23 as first or senior author since 2016. Most recent first- or senior-author papers:
- Int J Surg, 2026 (senior author): Predictive model and novel classification of pancreatic fistula following minimally invasive enucleation: a prospective cohort study (CSPAC-MIEN-2). PubMed 41731864
- Acta Pharmacol Sin, 2025 (senior author): Acyl-CoA thioesterase 8 induces gemcitabine resistance via regulation of lipid metabolism and antiferroptotic activity in pancreatic ductal adenocarcinoma. PubMed 39939803
- Cancer Lett, 2025 (senior author): Pentose phosphate recycling driven by Gli1 contributes to chemotherapy resistance in cancer cells. PubMed 40090571
- Surg Oncol, 2024 (senior author): A ligamentum teres hepatis and falciform ligament 'belt and braces' approach in laparoscopic pancreaticoduodenectomy using a modified Blumgart anastomosis to minimize severe pancreatic fistula and post-operative complications. PubMed 39395315
- Ann Surg Oncol, 2024 (senior author): Laparoscopic Duodenum and Spleen-Preserving Subtotal or Total Pancreatectomy: A Parenchyma-Sparing Strategy for Main Duct Intraductal Papillary Mucinous Neoplasms (with Video). PubMed 39312053
- Surg Endosc, 2024 (senior author): Evaluating the efficacy of laparoscopic radical antegrade modular pancreatosplenectomy in selected early-stage left-sided pancreatic cancer: a propensity score matching study. PubMed 38750173
- Mol Cancer, 2024 (senior author): Cancer immunometabolism: advent, challenges, and perspective. PubMed 38581001
- ANZ J Surg, 2024 (senior author): Reconsidering the role of prophylactic pancreaticojejunostomy in pancreatic enucleation: balancing the benefits and risks. PubMed 37985579
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion